Cinacalcet as rescue therapy for refractory hyperparathyroidism in young children with advanced chronic kidney disease

ConclusionsCinacalcet may be used effectively and safely in infants and small children with refractory sHPT in advanced CKD using a cautious dosing regimen. Cinacalcet successfully brings iPTH to target level and supports growth when other treatments have been ineffective.
Source: Pediatric Nephrology - Category: Urology & Nephrology Source Type: research